Search

Search results

32 results found

Hyaluronic acid (HA)-Gd(III) and HA-Fe(III) microgels as MRI contrast enhancing agents

Publication: Journal Article

Sahiner, Nurettin, Evrim Umut, Selin S. Suner, Mehtap Sahiner, Mustafa Culha, and Ramesh S. Ayyala. 2022. “Hyaluronic Acid (HA)-Gd(III) and HA-Fe(III) Microgels As MRI Contrast Enhancing Agents”. Carbohydrate Polymers 277: 118873.

Mesoporous, degradable hyaluronic acid microparticles for sustainable drug delivery application

Publication: Journal Article

Sahiner, Nurettin ", Selin S Suner, and Ramesh S" Ayyala. 2019. “Mesoporous, Degradable Hyaluronic Acid Microparticles for Sustainable Drug Delivery Application”. Colloids Surf. B Biointerfaces 177: 284-93.

Polyethyleneimine modified poly(Hyaluronic acid) particles with controllable antimicrobial and anticancer effects

Publication: Journal Article

Sahiner, Nurettin ", Selin Sagbas, Mehtap and Sahiner, and Ramesh S Ayyala. 2017. “Polyethyleneimine Modified Poly(Hyaluronic Acid) Particles With Controllable Antimicrobial and Anticancer Effects”. Carbohydr. Polym. 159: 29-38.

Creation of a drug-coated glaucoma drainage device using polymer technology: in vitro and in vivo studies

Publication: Journal Article

Sahiner, Nurettin, Daniel J Kravitz, Rabah and Qadir, Diane A Blake, Salima Haque, Vijay T John, Curtis E Margo, and Ramesh S Ayyala. 2009. “Creation of a Drug-Coated Glaucoma Drainage Device Using Polymer Technology: In Vitro and in Vivo Studies”. Arch. Ophthalmol. 127 (4): 448-53.

ESI-IM-MS characterization of cyclodextrin complexes and their chemically cross-linked alpha (α-), beta (β-) and gamma (γ-) cyclodextrin particles as promising drug delivery materials with improved bioavailability

Publication: Journal Article

Yilmaz, Aynur Sanem, Serhat Ozturk, Bekir Salih, Ramesh S. Ayyala, and Nurettin Sahiner. 2023. “ESI-IM-MS Characterization of Cyclodextrin Complexes and Their Chemically Cross-Linked Alpha (α-), Beta (β-) and Gamma (γ-) Cyclodextrin Particles As Promising Drug Delivery Materials With Improved Bioavailability”. Colloids and Surfaces B: Biointerfaces 230: 113522.

Physically Crosslinked Chondroitin Sulfate (CS)–Metal Ion (M: Fe(III), Gd(III), Zn(II), and Cu(II)) Particles for Versatile Applications and Their Biosafety

Publication: Journal Article

Suner, Selin S., Mehtap Sahiner, Evrim Umut, Ramesh S. Ayyala, and Nurettin Sahiner. 2023. “Physically Crosslinked Chondroitin Sulfate (CS)–Metal Ion (M: Fe(III), Gd(III), Zn(II), and Cu(II)) Particles for Versatile Applications and Their Biosafety”. Pharmaceuticals 16 (4).

Degradable and Non-Degradable Chondroitin Sulfate Particles with the Controlled Antibiotic Release for Bacterial Infections

Publication: Journal Article

Suner, Selin S., Mehtap Sahiner, Ramesh S. Ayyala, and Nurettin Sahiner. 2022. “Degradable and Non-Degradable Chondroitin Sulfate Particles With the Controlled Antibiotic Release for Bacterial Infections”. Pharmaceutics 14 (8).

Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels

Publication: Journal Article

Blake, Diane A ", Nurettin Sahiner, Vijay T and John, Antoine D Clinton, Korianne E Galler, Molly Walsh, Analisa Arosemena, Pamela Y Johnson, and Ramesh S Ayyala. 2006. “Inhibition of Cell Proliferation by Mitomycin C Incorporated into P(HEMA) Hydrogels”. J. Glaucoma 15 (4): 291-98.

Ramesh Ayyala, MD, FRCS, FRCOphth

Person: Chair, USF Department of Ophthalmology, James P. and Heather Gills Endowed Chair, Professor, USF Department of Ophthalmology

Dr. Ayyala is an internationally renowned board-certified ophthalmologist, specializing in anterior segment pathology and glaucoma, that has dedicated over 30 years to technological and scientific advancements in ophthalmology. He completed his medical degree at Gandhi Medical College and his...

Poly(Glycerol) Microparticles as Drug Delivery Vehicle for Biomedical Use

Publication: Journal Article

Sahiner, Mehtap, Aynur S. Yilmaz, Ramesh S. Ayyala, and Nurettin Sahiner. 2023. “Poly(Glycerol) Microparticles As Drug Delivery Vehicle for Biomedical Use”. Pharmaceutics 15 (2).